The global Cancer Immunotherapy Market was valued at USD 153.3 billion in 2025 and is projected to grow from USD 166.4 billion in 2026 to USD 305.8 billion by 2033, registering a CAGR of 9.0% from 2026 to 2033. North America dominated the global market with the largest revenue share of 43.3% in 2025, primarily driven by the increasing prevalence of cancer, continuous innovation in...

The US Immunotherapy Drugs Market represents the largest share of the global market, driven by a high prevalence of cancer and autoimmune disorders, substantial healthcare spending, and strong investments in biopharmaceutical research and development. The country is home to many leading pharmaceutical and biotechnology companies actively developing innovative immunotherapy treatments, including...